NGHL.F Stock Overview
A health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Nightingale Health Oyj Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.75 |
| 52 Week High | €1.75 |
| 52 Week Low | €1.75 |
| Beta | 0.70 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 0% |
Recent News & Updates
Recent updates
Shareholder Returns
| NGHL.F | US Healthcare | US Market | |
|---|---|---|---|
| 7D | 0% | 4.2% | 2.3% |
| 1Y | n/a | 6.9% | 35.1% |
Return vs Industry: Insufficient data to determine how NGHL.F performed against the US Healthcare industry.
Return vs Market: Insufficient data to determine how NGHL.F performed against the US Market.
Price Volatility
| NGHL.F volatility | |
|---|---|
| NGHL.F Average Weekly Movement | n/a |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 2.9% |
Stable Share Price: NGHL.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine NGHL.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2002 | 81 | Teemu Suna | nightingalehealth.com |
Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks. The company’s blood analysis technology measures various biomarkers from a single blood sample and identifies personal risks of disease using health data assets. It serves healthcare industry and researchers in Finland, the United Kingdom, rest of Europe, and internationally.
Nightingale Health Oyj Fundamentals Summary
| NGHL.F fundamental statistics | |
|---|---|
| Market cap | US$266.15m |
| Earnings (TTM) | -US$19.96m |
| Revenue (TTM) | US$4.04m |
65.9x
P/S Ratio-13.3x
P/E RatioIs NGHL.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NGHL.F income statement (TTM) | |
|---|---|
| Revenue | €3.65m |
| Cost of Revenue | €884.00k |
| Gross Profit | €2.77m |
| Other Expenses | €20.83m |
| Earnings | -€18.06m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 20, 2024
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 75.81% |
| Net Profit Margin | -494.23% |
| Debt/Equity Ratio | 1.7% |
How did NGHL.F perform over the long term?
See historical performance and comparison